Overview
Mark Hobeika is a General Surgeon in Houston, Texas. Dr. Hobeika is highly rated in 9 conditions, according to our data. His top areas of expertise are End-Stage Renal Disease (ESRD), Enlarged Liver, Visceromegaly, Liver Transplant, and Kidney Transplant.
His clinical research consists of co-authoring 48 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6411 Fannin St, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Office
Ching-wei Tzeng is a General Surgeon in Houston, Texas. Dr. Tzeng is highly rated in 30 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Hepatectomy, and Pancreatectomy.
UT MD Anderson Cancer Center
Keila Torres is a General Surgeon in Houston, Texas. Dr. Torres is highly rated in 25 conditions, according to our data. Her top areas of expertise are Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, Fibrosarcoma, and Lymphadenectomy.
MD Anderson
Funda Meric is a General Surgeon and a Surgical Oncologist in Houston, Texas. Dr. Meric is highly rated in 19 conditions, according to our data. Her top areas of expertise are PIK3CA-Related Overgrowth Spectrum, Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, and Mastectomy.
Frequently Asked Questions about Dr. Mark Hobeika
How do I make an appointment with Dr. Mark Hobeika?
You can book an appointment with Dr. Mark Hobeika by calling their office at 713-704-4071. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Hobeika a top-rated expert for Liver Transplant?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Hobeika is classified as an Distinguished expert for Liver Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Hobeika specialize in?
While Dr. Mark Hobeika is a General Surgery, they have specific expertise in Liver Transplant, Kidney Transplant, and End-Stage Renal Disease (ESRD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.
Does Dr. Mark Hobeika participate in research or clinical trials?
Yes. Dr. Mark Hobeika has published 48 articles and abstracts on conditions like Liver Transplant. You can view a list of Dr. Mark Hobeika's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Hobeika accept my insurance?
Dr. Mark Hobeika accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 713-704-4071 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Kidney TransplantDr. Hobeika isDistinguished. Learn about Kidney Transplant.
- Liver TransplantDr. Hobeika isDistinguished. Learn about Liver Transplant.
- Advanced
- End-Stage Renal Disease (ESRD)Dr. Hobeika isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Enlarged LiverDr. Hobeika isAdvanced. Learn about Enlarged Liver.
- Liver FailureDr. Hobeika isAdvanced. Learn about Liver Failure.
- Pancreas TransplantDr. Hobeika isAdvanced. Learn about Pancreas Transplant.
- Pignata Guarino SyndromeDr. Hobeika isAdvanced. Learn about Pignata Guarino Syndrome.
- Simultaneous Pancreas Kidney Transplant
- Experienced
- Alcoholic CirrhosisDr. Hobeika isExperienced. Learn about Alcoholic Cirrhosis.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Hobeika isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Chronic Antibody-Mediated RejectionDr. Hobeika isExperienced. Learn about Chronic Antibody-Mediated Rejection.
- CirrhosisDr. Hobeika isExperienced. Learn about Cirrhosis.
- EndoscopyDr. Hobeika isExperienced. Learn about Endoscopy.
- Fibrolamellar CarcinomaDr. Hobeika isExperienced. Learn about Fibrolamellar Carcinoma.